Early access. The directory is still filling out, and every rating here comes from a researcher's reported experience.

Security releases

TÜBİTAK BİLGEM Software Technologies Research Institute

CVE-2026-19731: Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in TÜBİTAK BİLGEM Software Technologies Research Institute İmzager

CVE-2026-19731 Nov 4, 2026 Source: Vendor

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in TÜBİTAK BİLGEM Software Technologies Research Institute İmzager allows Path Traversal.

This issue affects İmzager: from 2.10.5 before 2.10.7.

Source of record The credited names below are quoted verbatim from the vendor's own advisory: https://nvd.nist.gov/vuln/detail/CVE-2026-19731
Are you credited here? Sign in to claim your line. It is yours immediately, with no review queue. The name the vendor printed stays next to your handle for anyone to check against the advisory above, and any member who thinks a claim is wrong can refute it.

Credited

1 line
No lines match. , clear filters
Nothing here matches those filters. Clear them to see all 1 lines.